CUMBERLAND, R.I.—Onset Therapeutics, a specialty pharmaceutical company focused in dermatology, announced positive results from a skin moisturization study comparing BenzEFoam™ (benzoyl peroxide 5.3 percent) Emollient Foam to a combination gel containing clindamycin 1 percent - benzoyl peroxide 5 percent. According a poster presented Fall Clinical Dermatology Conference on Oct. 15 to 18, 2009, “Efficacy of benzoyl peroxide (5.3 percent) emollient foam and benzoyl peroxide (8 percent) wash in reducing Propionibacterium acnes on the back”, BenzEFoam provided greater skin hydration (statistically significant) than the combination gel at all time points over an eight-hour period post application.
The study evaluated the reduction of the acne-causing bacteria Propionibacterium acnes (P. Acnes) on the back after treatment with an acne medication. Total P. acnes colony counts on patients' backs were reduced by more than 99 percent after two weeks of treatment with BenzEFoam. In contrast, a benzoyl peroxide 8 percent wash applied in the shower failed to significantly reduce P. acnes counts on the back after two full weeks of treatment.